UBC Faculty Research and Publications

A Systematic Review of the Harms of Bisphosphonates Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 84 reviews the evidence for harms associated with long-term use of alendronate, etidronate, and risedronate. Conclusions: Systematic reviews assessing harms using observational studies are more difficult to conduct than traditional systematic reviews of RCTs assessing benefits. Bisphosphonates are associated with serious harms that are of similar clinical significance to their benefits. In secondary prevention, the small benefits of bisphosphonates likely outweigh the harms during the first 3 years of therapy, but harms likely outweigh benefits for durations greater than 3 years.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International